← Leaderboards
Tayyaba Hasan
Massachusetts General Hospital
$21,611,486
Attributed
$26,073,624
Total exposure
24
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,520,809 · 25
By mechanism
P01$29,510,468 · 10
R01$13,676,546 · 6
UH3$2,729,559 · 1
U01$1,754,252 · 1
UH2$995,302 · 1
RC1$971,294 · 1
Top collaborators
- Brian William Pogue11 shared
- Jonathan P Celli10 shared
- Rongguang Liang3 shared
- Edward V. Maytin3 shared
- Akilan Palanisami2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jonathan P Celli$3,483,846
- Nathaniel M Alpert$2,012,803
- Edward T. Ryan$44,052,519
- Daniel S Kohane$17,057,196
- Akilan Palanisami$194,878
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageBaseTumorResponseMalignant NeoplasmsLightPuva PhotochemotherapyDesignModalityMonitorProgramsCollaborationsTechnologyPhotochemistryMolecularIn VivoImage GuidedDosimetryClinical ResearchTreatment ResponseToxic EffectFluorescenceEpidermal Growth Factor ReceptorPhotosensitizing Agents
Grant awards (99)
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings$549,428
U01 · FY2025 · CA
Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapy$496,582
R01 · FY2025 · CA · contact PI
Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response$1,002,287
P01 · FY2024 · CA · contact PI
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings$537,737
U01 · FY2024 · CA · contact PI
Project 3: Immune Checkpoint Inhibition Therapy Enhanced by Integrated Photodynamic Treatment and Image Guidance in Preclinical Models of Pancreatic Cancer$217,561
P01 · FY2024 · CA · contact PI
Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapy$209,003
R01 · FY2024 · CA · contact PI
Core A: Administration, Integration, Education and Career Development$109,235
P01 · FY2024 · CA · contact PI
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings$29,163
U01 · FY2024 · CA · contact PI
Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response$1,202,445
P01 · FY2023 · CA · contact PI
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings$637,924
U01 · FY2023 · CA · contact PI
Project 3: Immune Checkpoint Inhibition Therapy Enhanced by Integrated Photodynamic Treatment and Image Guidance in Preclinical Models of Pancreatic Cancer$176,620
P01 · FY2023 · CA · contact PI
Core A: Administration, Integration, Education and Career Development$98,756
P01 · FY2023 · CA · contact PI
Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response$1,274,917
P01 · FY2022 · CA · contact PI
Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapy$737,109
R01 · FY2022 · CA · contact PI
Project 3: Immune Checkpoint Inhibition Therapy Enhanced by Integrated Photodynamic Treatment and Image Guidance in Preclinical Models of Pancreatic Cancer$250,024
P01 · FY2022 · CA · contact PI
Core A: Administration, Integration, Education and Career Development$125,496
P01 · FY2022 · CA · contact PI
Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapy$359,181
R01 · FY2021 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,035,201
P01 · FY2020 · CA · contact PI
Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapy$617,122
R01 · FY2020 · CA · contact PI
Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapy$646,771
R01 · FY2019 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$366,904
P01 · FY2019 · CA · contact PI
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$293,908
UH3 · FY2019 · CA · contact PI
Optical imaging guided resection and photodynamic therapy of glioma with targeted photoactivable agents$130,321
R21 · FY2019 · CA · contact PI
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer$64,017
P01 · FY2019 · CA · contact PI
Core A: Administration, Integration, Education, and Career Development$36,492
P01 · FY2019 · CA · contact PI
17th Biennial International Photodynamic Association World Congress$15,000
R13 · FY2019 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,458,454
P01 · FY2018 · CA · contact PI
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$521,175
UH3 · FY2018 · CA · contact PI
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer$262,683
P01 · FY2018 · CA · contact PI
Core A: Administration, Integration, Education, and Career Development$141,200
P01 · FY2018 · CA · contact PI
Optical imaging guided resection and photodynamic therapy of glioma with targeted photoactivable agents$128,564
R21 · FY2018 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,421,276
P01 · FY2017 · CA · contact PI
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$924,707
UH3 · FY2017 · CA · contact PI
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer$228,855
P01 · FY2017 · CA · contact PI
Rapid treatment guidance for antibiotic-resistant disease at the point of care$178,261
R21 · FY2017 · TW · contact PI
Core A: Administration, Integration, Education, and Career Development$140,612
P01 · FY2017 · CA · contact PI
Optical imaging guided resection and photodynamic therapy of glioma with targeted photoactivable agents$131,120
R21 · FY2017 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,419,849
P01 · FY2016 · CA · contact PI
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$989,769
UH3 · FY2016 · CA · contact PI
Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations$367,787
R01 · FY2016 · CA · contact PI
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer$222,911
P01 · FY2016 · CA · contact PI
Rapid treatment guidance for antibiotic-resistant disease at the point of care$211,494
R21 · FY2016 · TW · contact PI
Core A: Administration, Integration, Education, and Career Development$142,629
P01 · FY2016 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,477,552
P01 · FY2015 · CA · contact PI
Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM$498,135
R01 · FY2015 · CA · contact PI
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$495,304
UH2 · FY2015 · CA · contact PI
Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry$387,435
R01 · FY2015 · CA · contact PI
Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations$356,850
R01 · FY2015 · CA · contact PI
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer$234,824
P01 · FY2015 · CA · contact PI
Core A: Administration, Integration, Education, and Career Development$148,186
P01 · FY2015 · CA · contact PI
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$499,998
UH2 · FY2014 · CA · contact PI
Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM$482,872
R01 · FY2014 · CA · contact PI
Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations$413,258
R01 · FY2014 · CA · contact PI
Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry$370,925
R01 · FY2014 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,334,595
P01 · FY2013 · CA · contact PI
Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM$467,509
R01 · FY2013 · CA · contact PI
Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations$451,626
R01 · FY2013 · CA · contact PI
Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry$374,237
R01 · FY2013 · CA · contact PI
Mechanism-Based Design of Combination Therapies for Pancreatic Cancer$185,820
P01 · FY2013 · CA · contact PI
Administration, Integration, Education, and Career Development$104,968
P01 · FY2013 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,418,960
P01 · FY2012 · CA · contact PI
VisualSonics Photoacoustic and Ultrasound Imaging System$912,195
S10 · FY2012 · OD · contact PI
Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM$499,924
R01 · FY2012 · CA · contact PI
Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry$399,919
R01 · FY2012 · CA · contact PI
Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations$390,388
R01 · FY2012 · CA · contact PI
Rapid Fluorescence-Based Determination of Antibiotic Susceptibility$176,433
U54 · FY2012 · EB · contact PI
Mechanism-Based Design of Combination Therapies for Pancreatic Cancer$172,309
P01 · FY2012 · CA · contact PI
Administration, Integration, Education, and Career Development$91,367
P01 · FY2012 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,334,228
P01 · FY2011 · CA · contact PI
Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM$531,939
R01 · FY2011 · CA · contact PI
Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry$418,641
R01 · FY2011 · CA · contact PI
Mechanism-Based Design of Combination Therapies for Pancreatic Cancer$182,268
P01 · FY2011 · CA · contact PI
Administration, Integration, Education, and Career Development$110,530
P01 · FY2011 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,440,392
P01 · FY2010 · CA · contact PI
Targeted Photoactivatable Nanocells to Image and Treat Metastic Ovarian Cancer$474,804
RC1 · FY2010 · CA · contact PI
Mechanism-Based Design of Combination Therapies for Pancreatic Cancer$196,439
P01 · FY2010 · CA · contact PI
Administration, Integration, Education, and Career Development$119,151
P01 · FY2010 · CA · contact PI
Molecular Response and Imaging-based Combination Strategies for Optimal PDT$1,452,483
P01 · FY2009 · CA · contact PI
Targeted Photoactivatable Nanocells to Image and Treat Metastic Ovarian Cancer$496,490
RC1 · FY2009 · CA · contact PI
Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate$487,364
R01 · FY2009 · CA · contact PI
Mechanism-Based Design of Combination Therapies for Pancreatic Cancer$181,842
P01 · FY2009 · CA · contact PI
Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate$156,414
R01 · FY2009 · CA · contact PI
Administration, Integration, Education, and Career Development$118,488
P01 · FY2009 · CA · contact PI
Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate$30,000
R01 · FY2009 · CA · contact PI
Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate$475,527
R01 · FY2008 · CA · contact PI
Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate$473,223
R01 · FY2007 · CA · contact PI
Photodestruction of Ovarian Cancer: ErbB3 Targeted Apta*$475,469
R01 · FY2006 · CA · contact PI
Experimental Photoimmunotherapy of Ovarian Cancer$354,729
R01 · FY2006 · AR · contact PI
Physical and Biological Determinants for Optimal PDT$1,584,723
P01 · FY2005 · CA
Photodestruction of Ovarian Cancer: ErbB3 Targeted$506,000
R01 · FY2005 · CA
Experimental Photoimmunotherapy of Ovarian Cancer$414,551
R01 · FY2005 · AR
Physical and Biological Determinants for Optimal PDT$1,545,620
P01 · FY2004 · CA
Experimental Photoimmunotherapy of Ovarian Cancer$416,540
R01 · FY2004 · AR
Physical and Biological Determinants for Optimal PDT$1,497,936
P01 · FY2003 · CA
Experimental Photoimmunotherapy of Ovarian Cancer$409,516
R01 · FY2003 · AR
Physical and Biological Determinants for Optimal PDT$1,461,377
P01 · FY2002 · CA
PHOTODYNAMIC THERAPY OF TUMORS--CONTROL AND METASTASES$0
P01 · FY2002 · CA
Physical and Biological Determinants for Optimal PDT$1,717,986
P01 · FY2001 · CA
PHOTODYNAMIC THERAPY OF TUMORS--CONTROL AND METASTASES$0
P01 · FY2001 · CA